Vertex Pharmaceuticals’ suzetrigine approved for FDA review: A breakthrough in pain management

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced a pivotal advancement in the treatment of acute pain. The U.S. Food and Drug Administration (FDA) has officially ... Read More